Cytokinetics stock rises on Sanofi's rights acquisition

Cytokinetics shares rose 4.8% after Sanofi announced it will acquire rights to aficamten for Greater China, highlighting growth potential in treating hypertrophic cardiomyopathy.

Teva stock soars on positive Phase 2b study results

Teva shares rose 17% after positive Phase 2b results for duvakitug, a drug for inflammatory bowel disease, showing promise in treating ulcerative colitis and Crohn’s disease.

Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 million

Novavax sells its Czech manufacturing facility to Novo Nordisk for $200 million to boost its vaccine pipeline and reduce costs, amid struggles with COVID-19 vaccine competition.

Sanofi announces its biggest China investment deal amid China-EU trade tensions

Sanofi plans a €1 billion investment in a new insulin production site in Beijing, marking its largest investment in China amidst evolving trade relations with the EU.

How Trump's picks may impact US healthcare stocks

Sanofi plans to change hospital drug-discount program

Drugmaker stocks slide as Trump taps vaccine skeptic RFK Jr for US health job

U.S. drugmaker shares fell after Trump appointed Robert F. Kennedy Jr. to lead health, raising investor concerns over vaccine policies and agency oversight.

European stocks head marginally lower; UK economy contracted in September

European stocks struggle as UK growth contracts, inflation rises in France, and crude prices drop amid China's economic concerns and increased U.S. oil inventories.

Europe's STOXX 600 falls as tech, healthcare shares drag

The STOXX 600 index fell 0.5% due to declines in technology and healthcare stocks, marking its fourth consecutive weekly drop amid concerns over U.S.-China relations and economic conditions.

Explainer-Who in the US benefits from $35 insulin?

Vice President Harris highlights insulin price cap achievements while advocacy groups point out ongoing costs and access issues for non-Medicare patients, urging broader regulatory changes.